3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
3
Unknown
2
Terminated
1
Recruiting
1
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Rejection, Psychology
1
Liver Neoplasms
1
Carcinoma, Hepatocellular
1
Interventions
lenvatinib
2
durvalumab
2
atezolizumab
2
Bevacizumab
2
tremelimumab
1
poly ICLC
1
camrelizumab
1
apatinib
1
Tissue Banks
1
Oxaliplatin
1
Nivolumab
1
Liver Transplantation
1
Leucovorin
1
Ipilimumab
1
Hepatectomy
1
Gemcitabine
1
Folfox protocol
1
Fluorouracil
1
Dextrins
1
Cisplatin
1
Capecitabine
1
Blood Specimen Collection
1
Bariatric Surgery
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Not yet recruiting
×
Liver Neoplasms
×
Liver Transplantation
×
Clear all
NCT05951231
2023-11-01
EVOLVE
Oslo University Hospital
Phase NA
Not yet recruiting
22 enrolled